Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

Bibliographic Details
Main Authors: Mathilde Scarton, Anne Oppenheimer, Khalil Chaïbi, Didier Dreyfuss, Stéphane Gaudry
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Critical Care
Online Access:http://link.springer.com/article/10.1186/s13054-019-2447-0

Internet

http://link.springer.com/article/10.1186/s13054-019-2447-0

Similar Items